271 related articles for article (PubMed ID: 16411655)
1. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
Scholl PF; McCoy L; Kensler TW; Groopman JD
Chem Res Toxicol; 2006 Jan; 19(1):44-9. PubMed ID: 16411655
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
[TBL] [Abstract][Full Text] [Related]
4. Detectable levels of serum aflatoxin B1-albumin adducts in the United Kingdom population: implications for aflatoxin-B1 exposure in the United Kingdom.
Turner PC; Dingley KH; Coxhead J; Russell S; Garner CR
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):441-7. PubMed ID: 9610795
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
Scholl PF; Turner PC; Sutcliffe AE; Sylla A; Diallo MS; Friesen MD; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):823-6. PubMed ID: 16614131
[TBL] [Abstract][Full Text] [Related]
6. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
7. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns.
Sotomayor RE; Washington M; Nguyen L; Nyang'anyi R; Hinton DM; Chou M
Toxicol Sci; 2003 Jun; 73(2):329-38. PubMed ID: 12700393
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry.
McCoy LF; Scholl PF; Schleicher RL; Groopman JD; Powers CD; Pfeiffer CM
Rapid Commun Mass Spectrom; 2005; 19(16):2203-10. PubMed ID: 16015671
[TBL] [Abstract][Full Text] [Related]
9. Determination of Aflatoxin B1-Lysine in Pig Serum and Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Di Gregorio MC; Jager AV; Costa AA; Bordin K; Rottinhghaus GE; Petta T; Souto PC; Budiño FE; Oliveira CA
J Anal Toxicol; 2017 Apr; 41(3):236-241. PubMed ID: 27979927
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.
Wild CP; Jiang YZ; Sabbioni G; Chapot B; Montesano R
Cancer Res; 1990 Jan; 50(2):245-51. PubMed ID: 2104776
[TBL] [Abstract][Full Text] [Related]
11. Enzyme immunoassay for aflatoxin B1-lysine adduct and its validation.
Sujatha N; Suryakala S; Rao BS
J AOAC Int; 2001; 84(5):1465-74. PubMed ID: 11601466
[TBL] [Abstract][Full Text] [Related]
12. How does airway exposure of aflatoxin B1 affect serum albumin adduct concentrations? Evidence based on epidemiological study and animal experimentation.
Mo X; Lai H; Yang Y; Xiao J; He K; Liu C; Chen J; Lin Y
J Toxicol Sci; 2014 Aug; 39(4):645-53. PubMed ID: 25056789
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Validity of Normalizing Aflatoxin B
Smith JW; Ng DK; Alvarez CS; Egner PA; Burke SM; Chen JG; Kensler TW; Koshiol J; Rivera-Andrade A; Kroker-Lobos MF; Ramírez-Zea M; McGlynn KA; Groopman JD
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324659
[TBL] [Abstract][Full Text] [Related]
14. Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry.
Egner PA; Groopman JD; Wang JS; Kensler TW; Friesen MD
Chem Res Toxicol; 2006 Sep; 19(9):1191-5. PubMed ID: 16978023
[TBL] [Abstract][Full Text] [Related]
15. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
16. [Detection of aflatoxin-albumin adducts in human serum and its application].
Sun G; He X; Qian G; Pu Y
Wei Sheng Yan Jiu; 2001 May; 30(3):185-8. PubMed ID: 12525098
[TBL] [Abstract][Full Text] [Related]
17. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M
Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B
Xue KS; Cai W; Tang L; Wang JS
Food Chem Toxicol; 2016 Dec; 98(Pt B):210-219. PubMed ID: 27816556
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis.
Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM
Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216
[TBL] [Abstract][Full Text] [Related]
20. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
Vidyasagar T; Sujatha N; Sashidhar RB
Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
